G. Raghu (Seattle, Wa, United States of America), C. Robalo Cordeiro (Coimbra, Portugal)
Inhibition of local fibrinolysis differs between idiopathic pulmonary fibrosis (IPF) and fibrotic non-specific interstitial pneumonia (f-NSIP)
P. Bresser, M. Levi, P. Sterk (Amsterdam, Netherlands)
|  |
Pulmonary fibrosis is associated with emphysema in systemic sclerosis: indirect support for a smoking pathogenesis hypothesis
K. Antoniou, G. Margaritopoulos, S. R. Desai, D. Hansell, M. Rubens, R. C. Tennant, T. T. Hansel, N. Siafakas, R. DuBois, A. Wells (Heraklion Crete, London, Greece)
| |
Comparative study of current practice in the diagnosis and management of idiopathic pulmonary fibrosis between Japan and USA
J. Usuki, A. Azuma, A. Gemma, K. Chida, M. Bando, Y. Sugiyama, T. Nukiwa, S. Kudoh, L. Lancaster, H. Collard (Tokyo, Hamamatsu, Shimotsuke, Sendai, Kiyose, Japan; Nashville, San Francisco, United States Of America)
| |
Pirfenidone treatment for idiopathic pulmonary fibrosis (IPF): a comprehensive analysis of safety
R. Du Bois, C. Albera, W. Bradford, U. Costabel, T. King, S. Sahn, J. Szwarcberg, D. Valeyre, P. Noble (Denver, Brisbane, San Francisco, Charleston, Durham, United States Of America; Turin, Italy; Essen, Germany; Paris, France)
| |
Respiratory infections in patients with idiopathic pulmonary fibrosis (IPF)
B. Loeh, A. Baumann, W. Seeger, A. Guenther, P. Markart (Giessen, Germany)
| |
Combined pulmonary emphysema and fibrosis in connective tissue disease
V. Cottin, H. Nunes, A. Bérezné, R. Lazor, E. Hachulla, S. Hirschi, E. Marchand, A. Tazi, D. Valeyre, J. F. Cordier, GERMOP (Lyon, Paris, Lille, Strasbourg, France; Lausanne, Switzerland; Yvoir, Belgium)
| |
CTGF and TNFa expression in alveolar macrophages of patients with idiopathic pulmonary fibrosis before and after treatment with azathioprine and interferon-g
A. Xifteri, F. Drakopanagiotakis, E. Tsiambas, A. Karameris, K. Tsakanika, V. Polychronopoulos, D. Bouros (Maroussi, Athens, Alexandroupolis, Greece)
| |